Back to Previous Page

Posts

Posted:

Brain Health Healthspan and Longevity Hood Lab
New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?

New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?

There is tremendous market and media frenzy around new Alzheimer’s disease drugs, but their efficacy is contested while the potential of prevention is untapped and underreported, Drs. Lee Hood and Nathan Price wrote in an opinion piece published by the Los Angeles Times.

New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?
New Alzheimer’s drugs are costly and controversial. Are we going about this all wrong?
soldier

Posted:

Chronic Illness Hood Lab Neurological Disorders
ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury

ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury

Mild traumatic brain injury (mTBI) has been a frequent injury among U.S. combatants, and blast-related mTBI has been called the “signature injury” from military conflicts in Iraq and Afghanistan. ISB researchers are working to develop new methods to identify molecular changes in the blood of war veterans diagnosed with chronic mTBI.

ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury
ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury